← back to search

David A. Palma

Western University · CA
Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, Advanced Radiotherapy Techniques, Head and Neck Cancer Studies, and Radiomics and Machine Learning in Medical Imaging.
h-index
66
citations
21,897
works
657
NIH funding
primary concept
Medicine
email

Recent publications

Clinical Implementation of Simulation-Free Palliative Radiation Therapy: Consensus Recommendations From a Modified Delphi Study
Advances in Radiation Oncology 2026cited by 1position: contributordoi
The SABR Origin Story: An Interview With 3 Pioneers
International Journal of Radiation Oncology*Biology*Physics 2026cited by 0position: contributordoi
Inconsistent Definitions of Local Control for Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer – A Systematic Review
2026cited by 0position: contributordoi
A reirradiation workflow for managing patients with treatments planned in a multi-TPS environment
Technical Innovations & Patient Support in Radiation Oncology 2026cited by 0position: contributordoi
Recovery at the Edge of the Limits
International Journal of Radiation Oncology*Biology*Physics 2026cited by 0position: contributordoi
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
2025cited by 27position: contributordoi
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical Outcomes
International Journal of Radiation Oncology*Biology*Physics 2025cited by 5position: contributordoi
Impact of an Etoposide Chemotherapy Shortage on Patients With Extensive-Stage Small-Cell Lung Cancer: Results of a Natural Experiment.
2025cited by 2position: contributordoi
Impact of Transoral Robotic Surgery Versus Radiation on Swallowing Function in Oropharyngeal Cancer Patients: A Sub-Study From a Randomized Trial.
2025cited by 2position: contributordoi
A Thousand Data Points, One Clear Message: SFRT-1000 Demonstrates the Real-World Effectiveness of Simulation-Free Palliative Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics 2025cited by 1position: contributordoi
Response to “Reappraising OPTIMAL-HN: pragmatic progress or premature pivot in RIM pain management?”
Radiotherapy and Oncology 2025cited by 0position: contributordoi
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
Cell Reports 2024cited by 67position: middledoi
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology
The Lancet Oncology 2024cited by 34position: middledoi
Diagnostic CT-Enabled Planning (DART): Results of a Randomized Trial in Palliative Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics 2024cited by 24position: contributordoi
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial.
2024cited by 23position: contributordoi
A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomas.
2024cited by 3position: contributordoi
HPV-negative head and neck cancers with adverse pathological features carry specific molecular changes that are associated with survival.
2024cited by 2position: contributordoi
Outcomes for potentially Resectable patients undergoing primary chemoradiation treatment for T1-T2 HPV Negative oropharyngeal squamous cell carcinoma.
2024cited by 0position: contributordoi
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes.
2022cited by 138position: contributordoi
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
2022cited by 110position: contributordoi
Practical Management of Oligometastatic Non-Small-Cell Lung Cancer.
2022cited by 78position: contributordoi
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification
EBioMedicine 2022cited by 36position: middledoi
Oligometastases: Emerging Evidence.
2022cited by 29position: contributordoi
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial.
2022cited by 20position: contributordoi
Is Remote Learning as Effective as In-Person Learning for Contouring Education? A Prospective Comparison of Face-to-Face versus Online Delivery of the Anatomy and Radiology Contouring Bootcamp
International Journal of Radiation Oncology*Biology*Physics 2022cited by 17position: contributordoi
DART: diagnostic-CT-enabled planning: a randomized trial in palliative radiation therapy (study protocol).
2022cited by 13position: contributordoi
The Impact of Surgical Resectability on Outcomes for Patients Undergoing Primary Radiation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer
International Journal of Radiation Oncology*Biology*Physics 2022cited by 13position: contributordoi
Planning Trade-offs for SABR in Patients With 4 to 10 Metastases: A Substudy of the SABR-COMET-10 Randomized Trial
International Journal of Radiation Oncology*Biology*Physics 2022cited by 9position: contributordoi
Can We Identify Predictors of Success in Contouring Education for Radiation Oncology Trainees? An Analysis of the Anatomy and Radiology Contouring Bootcamp
Practical Radiation Oncology 2022cited by 3position: contributordoi
Oligometastases: Learning From the Past, Building for the Future
International Journal of Radiation Oncology*Biology*Physics 2022cited by 2position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 39 papers (2019–2026)Suresh Senan · Dutch Cancer Society11 papers (2013–2026)Anthony C. Nichols · Massachusetts General Hospital7 papers (2021–2025)Joe Mymryk · Lawson Health Research Institute7 papers (2020–2024)George Rodrigues · London Health Sciences Centre7 papers (2013–2019)Ramesh Rengan · University of Washington6 papers (2013–2019)Tae Hyun Kim · University of Science and Technology5 papers (2013–2015)Jeffrey D. Bradley · Hospital of the University of Pennsylvania5 papers (2013–2015)Sara Ramella · Associazione Italiana Di Oncologia Medica5 papers (2013–2015)Eric Winquist · Western University5 papers (2019–2024) · 5 papers (2013–2015)Lawrence B. Marks · University of North Carolina at Chapel Hill5 papers (2013–2015)Robert Olson · BC Cancer Agency4 papers (2019–2025)S. Danielle MacNeil · Western University4 papers (2022–2025)Matthias Gückenberger · Stadtspital Waid4 papers (2020–2026) · 4 papers (2013–2015)Michael Lock · Western University4 papers (2019–2025)Luigi De Petris · Karolinska University Hospital4 papers (2013–2015) · 4 papers (2013–2015)Sue S. Yom · UCSF Helen Diller Family Comprehensive Cancer Center4 papers (2019–2026)